Peer support for patients with type 2 diabetes in rural communities of China: protocol for a cluster randomized controlled trial

Bo Xie, Xiu-li Ye, Zi-lin Sun, Min Jia, Hui Jin, Chang-ping Ju, Li Yao, Carvalho Husni Da Costa De Vladmir, Yanxiaoxiao Yang, Bo Xie, Xiu-li Ye, Zi-lin Sun, Min Jia, Hui Jin, Chang-ping Ju, Li Yao, Carvalho Husni Da Costa De Vladmir, Yanxiaoxiao Yang

Abstract

Background: The prevalence of diabetes has been growing rapidly in developing countries. This causes devastating economic burdens and increases demands on the health care system. Therefore, there is an urgent need to find a cost-effective and multi-faceted approach for diabetes care. Peer support models provide a potentially low-cost, flexible means which complements the current existing health care services. In this way, trained peer leaders can become qualified extensions to a formal healthcare system, capable of assisting education delivery and bolstering the efforts of professional staff. As such, creating a cultural specific peer support program and determining whether it is acceptable and cost-effective in rural communities of China is crucial. This study aims to implement and evaluate biophysical and psychosocial outcomes of peer support program for people with type 2 diabetes in rural communities, and to explore the program's feasibility and sustainability in China.

Methods/design: This study is a cluster randomised controlled trial. All consenting patients will be randomised by community staff members to receive either peer support or the control care. The data collection and analysis including social demographics, health status, psychosocial status, economic status and biomedical measures will be collected at baseline, 6 months, and 12 months. The primary indicator measured is the change in HbA1c, whereas secondary indicators include biophysical, psychosocial functioning and other lifestyle factors. Finally, economic evaluations will determine whether the program is cost effective.

Discussion: This protocol is a cluster randomized, controlled trial of group-based peer support for people with type 2 diabetes in the community settings of rural China. Results from this trial may provide evidence to the effectiveness of peer support; furthermore, they will provide valuable information concerning the acceptability and feasibility of a new approach to improve diabetes self-management among resource-constrained settings.

Trial registration: ClinicalTrials.gov Identifier: NCT02119572, April 18, 2014.

Figures

Figure 1
Figure 1
Peer support for patients with type 2 diabetes in Nanjing--Consort diagram for diabetes project study design.

References

    1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi: 10.1016/j.diabres.2013.11.002.
    1. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. doi: 10.1016/j.diabres.2010.01.026.
    1. Zabetian A, Sanchez IM, Narayan KM, Hwang CK, Ali MK. Global rural diabetes prevalence: A systematic review and meta-analysis covering 1990–2012. Diabetes Res Clin Pract. 2014;104(2):206–213. doi: 10.1016/j.diabres.2014.01.005.
    1. Routasalo PE, Savikko N, Tilvis RS, Strandberg TE, Pitkala KH. Social contacts and their relationship to loneliness among aged people - a population-based study. Gerontology. 2006;52(3):181–187. doi: 10.1159/000091828.
    1. Ghorob A, Vivas MM, De Vore D, Ngo V, Bodenheimer T, Chen E, Thom DH. The effectiveness of peer health coaching in improving glycemic control among low-income patients with diabetes: protocol for a randomized controlled trial. BMC Public Health. 2011;11:208. doi: 10.1186/1471-2458-11-208.
    1. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, 2010 China Noncommunicable Disease Surveillance Group Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959. doi: 10.1001/jama.2013.168118.
    1. Shen H, Edwards H, Courtney M, McDowell J, Wu M. Peer-led diabetes self-management programme for community-dwelling older people in China: study protocol for a quasi-experimental design. J Adv Nurs. 2012;68(12):2766–2777. doi: 10.1111/j.1365-2648.2012.06059.x.
    1. Dennis C-L. Peer support within a health care context: a concept analysis. Int J Nurs Stud. 2003;40(3):321–332. doi: 10.1016/S0020-7489(02)00092-5.
    1. Boothroyd RI, Fisher EB. Peers for progress: promoting peer support for health around the world. Fam Pract. 2010;27(Suppl 1):i62–i68. doi: 10.1093/fampra/cmq017.
    1. Dale JR, Williams SM, Bowyer V. What is the effect of peer support on diabetes outcomes in adults? A systematic review. Diabet Med. 2012;29(11):1361–1377. doi: 10.1111/j.1464-5491.2012.03749.x.
    1. Heisler M. Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research. Fam Pract. 2010;27(Suppl 1):i23–i32. doi: 10.1093/fampra/cmp003.
    1. Sylvia S, Shi Y, Xue H, Tian X, Wang H, Liu Q, Medina A, Rozelle S. Health Policy Plan. 2014. Survey using incognito standardized patients shows poor quality care in China’s rural clinics.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c869–c879. doi: 10.1136/bmj.c869.
    1. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345(sep04 1):e5661–e5671. doi: 10.1136/bmj.e5661.
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–950. doi: 10.2337/diacare.23.7.943.
    1. Lorig K, Ritter PL, Villa FJ, Armas J. Community-based peer-led diabetes self-management: a randomized trial. Diabetes Educ. 2009;35(4):641–651. doi: 10.1177/0145721709335006.
    1. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
    1. Koltowska-Haggstrom M, Jonsson B, Isacson D, Bingefors K. Using EQ-5D to derive general population-based utilities for the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA) Value Health. 2007;10(1):73–81. doi: 10.1111/j.1524-4733.2006.00146.x.
    1. Wang HM, Patrick DL, Edwards TC, Skalicky AM, Zeng HY, Gu WW. Validation of the EQ-5D in a general population sample in urban China. Qual Life Res. 2012;21(1):155–160. doi: 10.1007/s11136-011-9915-6.
    1. EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–252. doi: 10.1370/afm.842.
    1. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–631. doi: 10.2337/diacare.28.3.626.
    1. Thompson ER. Development and validation of an internationally reliable short-form of the Positive and Negative Affect Schedule (PANAS) J Cross Cult Gerontol. 2007;38(2):227–242. doi: 10.1177/0022022106297301.
    1. Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49(1):71–75. doi: 10.1207/s15327752jpa4901_13.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–343. doi: 10.1016/0005-7967(94)00075-U.
    1. Chan RC, Xu T, Huang J, Wang Y, Zhao Q, Shum DH, O’Gorman J, Potangaroa R. Extending the utility of the Depression Anxiety Stress scale by examining its psychometric properties in Chinese settings. Psychiatry Res. 2012;200(2–3):879–883. doi: 10.1016/j.psychres.2012.06.041.
    1. The WHO STEPwise approach to surveillance (STEPS) []
    1. Hadden DR, Savage GA, Lappin TR, Elder GE. What is the gold standard for glycosylated haemoglobin? Lancet. 1993;342(8884):1424–1425. doi: 10.1016/0140-6736(93)92785-R.
    1. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA. 1996;276(15):1246–1252. doi: 10.1001/jama.1996.03540150048030.
    1. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991;325(12):836–842. doi: 10.1056/NEJM199109193251202.
    1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318(20):1315–1321. doi: 10.1056/NEJM198805193182007.
    1. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–1132. doi: 10.1002/hec.1124.
    1. World Health Organization . 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2009.
    1. Amer Diabet A. Standards of medical care in diabetes-2011 American Diabetes Association. Diabetes Care. 2011;34:S11–S61. doi: 10.2337/dc11-S011.
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir